Drug Type Bispecific antibody |
Synonyms STAR 002, STAR-002 |
Target |
Mechanism TCR modulators(T-cell receptor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Marengo Therapeutics, Inc.Startup |
Active Organization Marengo Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Discovery | US | Marengo Therapeutics, Inc.Startup | 02 Aug 2022 |